Shimizu M, Sekine K, Iwaguchi T, Kataoka T, Mori T
Dept. of Cancer Therapeutics, Tokyo Metropolitan Institute of Medical Science.
Gan To Kagaku Ryoho. 1990 Apr;17(4 Pt 1):639-43.
The S/F ratio of slow electrophoretic mobility cells (less than 0.95 micron/sec/V/cm) to fast mobility cells (greater than or equal to 0.95) increased significantly in the peripheral blood mononuclear cells of cancer patients. Since one of slow mobility cells was mainly composed of monocytes, the relationship between the mobility and the functions of monocytes in the peripheral blood of patients with cancer was examined. The cancer patients (total 27) consisted of 12 patients with rectum, 7 with colon, 3 with stomach, one with ovary and 4 with recurrent cancers and of 3 with stage 1, 11 with stage 2, 3 with stage 3 and 6 with stage 4 + 5. We determined the releases of interleukin 1 (IL-1) and prostaglandin E2 (PGE2) from monocytes, which were stimulated with lipopolysaccharide, as an index for the function of monocytes. The mobility of monocytes and productions of IL-1 and PGE2 from monocytes decreased with the stage of cancer patients, indicating a decreased function of monocytes in the patients. These findings suggest that S/F ratio of the peripheral blood mononuclear cells and mobility, IL-1 and PGE2 productions of monocytes are a good index for the judgement of treatment efficacy of cancer.
癌症患者外周血单个核细胞中,电泳迁移率慢的细胞(小于0.95微米/秒/伏/厘米)与迁移率快的细胞(大于或等于0.95)的S/F比值显著增加。由于迁移率慢的细胞之一主要由单核细胞组成,因此研究了癌症患者外周血中单核细胞迁移率与其功能之间的关系。癌症患者(共27例)包括12例直肠癌患者、7例结肠癌患者、3例胃癌患者、1例卵巢癌患者、4例复发癌患者,以及3例1期患者、11例2期患者、3例3期患者和6例4 + 5期患者。我们测定了用脂多糖刺激的单核细胞释放白细胞介素1(IL-1)和前列腺素E2(PGE2)的情况,以此作为单核细胞功能的指标。单核细胞的迁移率以及单核细胞产生IL-1和PGE2的能力随癌症患者分期的增加而降低,这表明患者单核细胞功能下降。这些发现提示,外周血单个核细胞的S/F比值以及单核细胞的迁移率、IL-1和PGE2产生量是判断癌症治疗效果的良好指标。